Acumen Pharmaceuticals's Earnings: A Preview
Portfolio Pulse from Benzinga Insights
Acumen Pharmaceuticals (NASDAQ:ABOS) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.36. The company's past performance shows a trend of beating EPS estimates, which has often resulted in a positive impact on the share price. The stock is currently trading at $7.3 and has seen a 37.52% increase over the last 52-week period.
August 07, 2023 | 9:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Acumen Pharmaceuticals is expected to release its earnings report, with an estimated EPS of $-0.36. The company has a history of beating estimates, which could potentially lead to a positive impact on the share price.
Acumen Pharmaceuticals has a history of beating EPS estimates, which has often resulted in a positive impact on the share price. Given this trend and the positive performance of the stock over the past year, it is likely that the upcoming earnings report could have a positive impact on the stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100